Skip to main content
. 2017 Aug 9;12(8):e0181886. doi: 10.1371/journal.pone.0181886

Table 2. Neutralization of tier-1 and tier-2 viruses in TZM-bl cell assaya.

Tier 1A Tier 2
Clade B Clade C Clade A Clade C Clade B CRF07 BC Clade B Clade C Clade AC CRF07 BC Clade A CRF01 AB
Regimen Animal ID Bleed Week Negative Control MN.3 MW965.26 BG505ΔCT/T332N 25710–2.43 TRO.11 BJOX002000.03.2 X1632-S2-B10 Ce1176 A3 246-F3 C10 2 CH119.10 Ce703010217 B6 CNE55
CC M17 10 <20 558 2819 73 <20 <20 <20 <20 <20 <20 <20 <20 <20
M19 10 <20 554 895 70 <20 <20 <20 <20 <20 <20 <20 <20 <20
M23 10 34 584 1207 40 32 32 28 35 28 35 40 27 24
F2 10 <20 714 802 33 <20 <20 <20 <20 <20 <20 <20 <20 <20
F21 10 <20 635 1690 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20
median <20 584 1207 40 <20 <20 <20 <20 <20 <20 <20 <20 <20
CCC M17 26 <20 <20 189 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20
M19 26 <20 <20 76 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20
M23 26 <20 <20 <20 36 <20 <20 <20 <20 <20 <20 <20 <20 <20
F2 26 <20 <20 65 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20
median <20 <20 71 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20
MMM M8 26 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20
F20 26 <20 <20 710 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20
F31 26 <20 <20 <20 311 <20 <20 <20 <20 <20 <20 <20 <20 <20
median <20 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20
PPP M10 26 <20 496 5296 559 <20 <20 <20 <20 <20 <20 <20 <20 <20
M12 26 <20 112 2171 925 <20 <20 <20 <20 <20 <20 <20 <20 <20
M27 26 <20 61 2385 45 <20 <20 <20 <20 <20 <20 <20 <20 <20
F4 26 <20 121 13856 150 80 29 <20 <20 77 <20 <20 <20 <20
F13 26 <20 1714 33189 41 <20 <20 <20 <20 <20 <20 <20 <20 <20
median <20 117 5296 150 <20 <20 <20 <20 <20 <20 <20 <20 <20
CPP M7 26 <20 235 8618 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20
F5 26 <20 879 1397 151 27 21 <20 <20 39 <20 <20 <20 <20
F6 26 <20 325 13309 553 <20 <20 <20 <20 <20 <20 <20 <20 <20
F22 26 <20 87 8532 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20
median <20 280 8575 76 <20 <20 <20 <20 <20 <20 <20 <20 <20
MPP M9 26 <20 467 1770 125 <20 <20 <20 <20 <20 <20 <20 <20 <20
M15 26 <20 521 8599 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20
M18 26 <20 1026 6008 400 42 <20 <20 <20 45 <20 <20 <20 <20
F29 26 <20 137 847 847 <20 <20 <20 <20 <20 <20 <20 <20 <20
median <20 494 3889 263 <20 <20 <20 <20 <20 <20 <20 <20 <20
CM M11 10 <20 1130 940 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20
F1 10 <20 20545 11454 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20
F3 10 <20 540 2770 90 <20 <20 <20 <20 <20 <20 <20 <20 <20
F26 10 <20 6558 2732 28 <20 <20 <20 <20 <20 <20 <20 <20 <20
M16 10 <20 2070 2071 245 <20 <20 <20 <20 <20 <20 <20 <20 <20
median <20 2070 2732 28 <20 <20 <20 <20 <20 <20 <20 <20 <20
CMP M11 26 <20 468 1470 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20
F1 26 <20 343 8624 37 <20 <20 <20 <20 <20 <20 <20 <20 <20
F3 26 <20 397 6355 2096 <20 <20 <20 <20 <20 <20 <20 <20 <20
F26 26 <20 6199 24627 1011 <20 <20 <20 <20 <20 <20 <20 <20 <20
median <20 432 7490 524 <20 <20 <20 <20 <20 <20 <20 <20 <20

a—Values are the serum dilution at which relative luminescence units (RLUs) were reduced 50% compared to virus control wells (no test sample). Highlighted bold values are considered positive for neutralization based on the criterion of signal ≤3x the signal of that sample against the MLV-pseudotyped negative-control virus.